Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
International Journal of Infectious Diseases
International Society for Infectious Diseases
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Supplements
  • Collections
    • Back
    • World TB Day 2023
    • World TB Day 2022
    • World TB Day 2021
    • IJID COVID-19
    • Emerging Infectious Diseases in the Time of Ebola
    • Featured Content
  • For Authors
    • Back
    • About Open Access
    • Author Information
    • Permissions
    • Researcher Academy 
    • Submit a Manuscript 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact Information
    • Editorial Board
    • Info for Advertisers 
    • Reprints 
    • New Content Alerts
  • News and Media
  • ISID 
  • ProMED 
  • More Periodicals
    • Back
    • Find a Periodical 
    • Go to Product Catalog 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Claim
x

Filter:

Filters applied

  • Coronavirus (COVID-19) Collection
  • TransmissionRemove Transmission filter
  • SARS-CoV-2Remove SARS-CoV-2 filter
Clear all

Article Type

  • Research Article6
  • Rapid Communication1

Publication Date

  • Last 3 Months1
  • Last 6 Months2
  • Last Year2
  • Last 2 Years4
  • Last 5 Years8
Please choose a date range between 2020 and 2023.

Author

  • Abdulrahman, Abdulkarim1
  • Adegnika, Ayola Akim1
  • Almadhi, Marwa Ali1
  • AlQahtani, Manaf M1
  • AlSaad, Dana1
  • Atkin, Stephen L1
  • Beldomenico, Pablo M1
  • Bikangui, Rodrigue1
  • Borrmann, Steffen1
  • Cao, Ting1
  • Chang, Luan-Yin1
  • Chen, Fang1
  • Chen, Jong-Min1
  • Chen, Lei1
  • Chen, Szu-Han1
  • Chen, Xiuzhi1
  • Cowling, Benjamin J1
  • Djoba Siawaya, Joël-Fleury1
  • Feng, Shuang1
  • Gao, Xuehuan1
  • Gong, Lei1
  • Gu, Xinxia1
  • Honkpehedji, Josiane Yabo1
  • Hou, Sai1
  • Huang, Chunxu1

Journal

  • International Journal of Infectious Diseases8

Keyword

  • COVID-195
  • Cycle threshold2
  • Asymptomatic1
  • B.1.1.3181
  • B.1.1.71
  • Bahrain1
  • Central Africa1
  • China1
  • Cluster infection1
  • Coronavirus disease 191
  • Coronavirus disease 20191
  • Ct1
  • Epidemiology1
  • Features1
  • Gabon1
  • Household1
  • Incubation period1
  • Intervention1
  • MinION1
  • Negative predictive value1
  • Non-pharmaceutical interventions1
  • NPV1
  • Omicron1

Access Filter

  • Open Access

Coronavirus (COVID-19) Collection

8 Results
Subscribe to collection
  • Export
    • PDF
    • Citation

Please select at least one article in order to proceed.

Ok
FilterHide Filter
  • Research Article
    Open Access

    Differential clinical characteristics and performance of home antigen tests between parents and children after household transmission of SARS-CoV-2 during the Omicron variant pandemic

    International Journal of Infectious Diseases
    Vol. 128p301–306Published online: January 12, 2023
    • Szu-Han Chen
    • Jhong-Lin Wu
    • Yun-Chung Liu
    • Ting-Yu Yen
    • Chun-Yi Lu
    • Luan-Yin Chang
    • and others
    Cited in Scopus: 0
    • Preview Hide Preview
    • Download PDF
    • Export Citation
      The SARS-CoV-2 Omicron variant (B.1.1.529) BA.2 pandemic struck in 2022. Children seemed to have a lower rate of infection than adults at the beginning of the COVID-19 pandemic, but the clinical scenario changed, especially after the Omicron variant outbreak [1]. The transmission of SARS-CoV-2 may vary according to different viral variants, settings, and individuals, and understanding the transmission rate and factors associated with transmission may help further control COVID-19. To this end, the difference in clinical symptoms and overall household transmission rate between children and adults needs further investigation.
      Differential clinical characteristics and performance of home antigen tests between parents and children after household transmission of SARS-CoV-2 during the Omicron variant pandemic
    • Research Article
      Open Access

      Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022

      International Journal of Infectious Diseases
      Vol. 126p132–135Published online: October 28, 2022
      • Hualei Xin
      • Zhe Wang
      • Shuang Feng
      • Zhou Sun
      • Lele Yu
      • Benjamin J Cowling
      • and others
      Cited in Scopus: 0
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        From the end of 2020, multiple variants of concern have emerged during the COVID-19 pandemic. Most recently, the Omicron variant has become dominant worldwide over other strains, with the potential for the emergence of other new variants or subvariants in the future. The Omicron variants have demonstrated increasing transmissibility and therefore are more challenging to control (Kraemer et al., 2021; World Health Organization, 2022). In general, increased transmissibility for a variant indicates an increased transmission strength, a higher transmission speed, or both.
        Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022
      • Short Communication
        Open Access

        Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon

        International Journal of Infectious Diseases
        Vol. 114p151–154Published online: November 3, 2021
        • Gédéon Prince Manouana
        • Moustapha Nzamba Maloum
        • Rodrigue Bikangui
        • Sam O'neilla Oye Bingono
        • Georgelin Ondo Nguema
        • Josiane Yabo Honkpehedji
        • and others
        Cited in Scopus: 6
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          SARS-CoV-2 variants of concern (VOC) appear to spread more easily. Other emerging variants are also gaining attention, either known as a "variants of interest" (VOI) or "variants under investigation" (VUI), which increase transmission, warranting further studies. Since the onset of the COVID-19 pandemic, the SARS-CoV-2 genomes have accumulated genetic diversity, leading to increased transmission with altered viral properties (Kraemer et al. 2021).
          Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon
        • Research Article
          Open Access

          Epidemiological and clinical features of SARS-CoV-2 cluster infection in Anhui Province, Eastern China

          International Journal of Infectious Diseases
          Vol. 117p372–377Published online: May 10, 2021
          • Jiabing Wu
          • Xiuzhi Chen
          • Lei Gong
          • Shaohu Huo
          • Xuehuan Gao
          • Shuang Nie
          • and others
          Cited in Scopus: 1
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            COVID-19, a new contagious respiratory disease, occurred at the end of 2019, in Wuhan, China (Zu et al., 2020), and spread globally rapidly. Although various endeavors have been taken, the disease has not been well controlled except in a few countries. Up to now, COVID-19 has led to over millions of deaths, and become a pandemic and global public health crisis. The pathogen of COVID-19 was quickly confirmed to be SARS-CoV-2 (Schijns et al., 2020).
            Epidemiological and clinical features of SARS-CoV-2 cluster infection in Anhui Province, Eastern China
          • Research Article
            Open Access

            The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19

            International Journal of Infectious Diseases
            Vol. 105p656–661Published online: February 26, 2021
            • Marwa Ali Almadhi
            • Abdulkarim Abdulrahman
            • Sayed Ali Sharaf
            • Dana AlSaad
            • Nigel J. Stevenson
            • Stephen L. Atkin
            • and others
            Cited in Scopus: 31
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              SARS-CoV-2, the virus causing Coronavirus disease 2019 (COVID-19), has infected more than 92 million people and lead to the death of more than 1.9 million people worldwide since its outbreak in December 2019 (WHO, 2020). The disease has a wide range of presentations, from asymptomatic infection to fever, cough, shortness of breath and the loss of taste and smell. Symptoms normally appear 2–14 days following exposure to the virus and may develop into mild upper respiratory tract infections or progress to severe pneumonia, which can progress to acute respiratory distress, shock, multiorgan failure and death (Huang et al., 2020; Wang et al., 2020).
              The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19
            • Research Article
              Open Access

              Surveillance of common respiratory infections during the COVID-19 pandemic demonstrates the preventive efficacy of non-pharmaceutical interventions

              International Journal of Infectious Diseases
              Vol. 105p442–447Published online: February 11, 2021
              • Qi Yang
              • Xia Xiao
              • Xinxia Gu
              • Dong Liang
              • Ting Cao
              • Jun Mou
              • and others
              Cited in Scopus: 8
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                The outbreak of novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-induced disease, COVID-19, spread rapidly from Wuhan, China, in December 2019. This led to China experiencing a major public health emergency with over 83,000 confirmed cases and 4634 deaths as of June 2020 (Rai et al., 2020). Although there are a few newly developed vaccines and treatments, it is conceivable that without some impact on transmission, the virus will continue to circulate, infect, and cause serious disease, in certain segments of the unvaccinated population.
                Surveillance of common respiratory infections during the COVID-19 pandemic demonstrates the preventive efficacy of non-pharmaceutical interventions
              • Research Article
                Open Access

                Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis

                International Journal of Infectious Diseases
                Vol. 100p42–49Published online: August 12, 2020
                • Wee Chian Koh
                • Lin Naing
                • Justin Wong
                Cited in Scopus: 55
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  A combination of physical distancing measures, if implemented early, can be effective in containing COVID-19—tight border controls to limit importation of cases, encouraging physical distancing, moderately stringent measures such as working from home, and a full lockdown in the case of a probable uncontrolled outbreak.
                  Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis
                • Perspective
                  Open Access

                  Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19

                  International Journal of Infectious Diseases
                  Vol. 96p461–463Published online: May 10, 2020
                  • Pablo M. Beldomenico
                  Cited in Scopus: 40
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    The patterns of propagation of the severe acute respiratory syndrome (SARS) outbreak of 2003 were not explained by conventional epidemic models that assumed homogeneity of infectiousness. Instead, the existing datasets were best matched by models that used negative binomial distributions, in which a small proportion of cases were highly infectious (Lloyd-Smith et al., 2005; McDonald et al., 2004; Shen et al., 2004). Data and modelling supported the existence of superspreaders, which played a crucial role in propagating the disease by being very efficient at transmitting SARS-CoV-1, such that in the absence of superspreading events most cases infected few, if any, secondary contacts (Stein, 2011).
                    Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19
                  Page 1 of 1
                  Skip menu

                    Login to your account

                    Show
                    Forgot password?
                    Don’t have an account?
                    Create a Free Account

                    If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

                    If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

                    Cancel
                    • Home
                    • Articles & Issues
                    • Articles In Press
                    • Current Issue
                    • List of Issues
                    • Supplements
                    • Collections
                    • IJID COVID-19
                    • Emerging Infectious Diseases in the Time of Ebola
                    • Featured Content
                    • For Authors
                    • About Open Access
                    • Author Information
                    • Permissions
                    • Researcher Academy
                    • Submit a Manuscript
                    • Journal Info
                    • About the Journal
                    • About Open Access
                    • Contact Information
                    • Editorial Board
                    • Info for Advertisers
                    • Reprints
                    • New Content Alerts
                    • News and Media
                    • ISID
                    • ProMED
                    • More Periodicals
                    • Find a Periodical
                    • Go to Product Catalog

                    The content on this site is intended for healthcare professionals.



                    We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
                    Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

                    • Privacy Policy  
                    • Terms and Conditions  
                    • Accessibility  
                    • Help & Contact

                    RELX